Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESI)

The summary for the Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESI) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESI): The Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESIs) provides support for ESIs with a program of research that aligns with the NIGMS mission.MIRA distributes funding among promising investigators across the country. The goal is to boost scientific productivity and the chances for important breakthroughs.Through this program, investigators can:Receive independent research funding early to start and sustain strong research careers.Explore new, unique research areas in the NIGMS mission.Take on ambitious, creative projects.Shift focus to include emerging techniques and technologies as needed.Devote more time to mentoring trainees in a stable research environment.

Federal Grant Title:	Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESI)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-27-032
Type of Funding:	Grant
CFDA Numbers:	93.859
CFDA Descriptions:	Information not provided
Current Application Deadline:	February 6th, 2029
Original Application Deadline:	February 6th, 2029
Posted Date:	May 12th, 2026
Creation Date:	May 12th, 2026
Archive Date:	April 7th, 2029
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	May 12th, 2026

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Refer to the Eligibility section in the NOFO for additional information on eligibility.Foreign institutions: Foreign components, as defined in the NIH Grants Policy Statement, are allowed.These types of organizations are not eligible to apply: Non-domestic (non-U.S.) entities (foreign institutions), Non-domestic (non-U.S.) components of U.S. organizations.
Grant Announcement Contact: National Institute of General Medical Sciences (NIGMS)
[email protected]
[email protected]
Similar Government Grants: • Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 ...; • Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational R...; • Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D...; • Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability P...; • Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial N...; • Tools for Genetic and Genomic Studies in Emerging Model Organisms; • Evolution of Infectious Diseases; • Mbrs Support of Continuous Research Excellence (Score)
More Grants from the National Institutes of Health: • Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not ...; • NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed); • Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional); • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...; • The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Researc...